|
GB9919413D0
(en)
*
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
AU7962200A
(en)
*
|
1999-10-29 |
2001-05-14 |
Wakunaga Pharmaceutical Co., Ltd |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
KR100863659B1
(ko)
*
|
2001-04-16 |
2008-10-15 |
미쓰비시 타나베 파마 코퍼레이션 |
질소-함유 헤테로시클릭 화합물 및 이를 포함하는 제약 조성물
|
|
AU2002323776B2
(en)
|
2001-08-10 |
2008-07-31 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-responsive receptor Delta
|
|
MXPA04003398A
(es)
|
2001-10-12 |
2004-11-22 |
Nippon Chemiphar Co |
Activador para el receptor o activado con el proliferador de peroxisoma.
|
|
AU2005275181A1
(en)
*
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
KR20070091607A
(ko)
*
|
2004-10-12 |
2007-09-11 |
디코드 제네틱스, 아이엔씨. |
폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
KR20080102181A
(ko)
*
|
2006-02-15 |
2008-11-24 |
알러간, 인코포레이티드 |
스핑고신-1-포스페이트 (에스1피) 수용체 길항제 생물학적 활성을 갖는 아릴 또는 헤테로아릴기를 포함하는 인돌-3-카르보실산 아미드, 에스테르, 티오아미드 및 티올 에스테르 화합물
|
|
JP5290749B2
(ja)
|
2006-04-18 |
2013-09-18 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体δの活性化剤
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
RU2008149518A
(ru)
*
|
2006-05-16 |
2010-06-27 |
Декод Дженетикс, Ехф. (Is) |
Способ получения 7-(акрилоил) индолов
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
CA2674946A1
(en)
|
2007-01-11 |
2008-07-24 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
US8648208B2
(en)
|
2008-04-15 |
2014-02-11 |
Nippon Chemiphar Co. Ltd. |
Activating agent for peroxisome proliferator activated receptor
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
BR112012022910B1
(pt)
|
2010-03-12 |
2021-08-10 |
Omeros Corporation |
Compostos inibidores de pde10, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos para tratar distúrbios neurológicos em um animal de sangue quente
|
|
JP5918264B2
(ja)
|
2010-12-22 |
2016-05-18 |
アッヴィ・インコーポレイテッド |
Ｃ型肝炎阻害剤およびその使用
|
|
HK1217488A1
(zh)
|
2013-02-21 |
2017-01-13 |
Adverio Pharma Gmbh |
{4,6-二氨基-2-[1-(2-氟苄基)-1h-吡唑并[3,4-b]吡啶-3-基]嘧啶-5-基}甲基氨基甲酸甲酯的形式
|
|
NZ716462A
(en)
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
PT3186233T
(pt)
*
|
2014-08-29 |
2021-12-02 |
Chdi Foundation Inc |
Sondas para imagem de proteína de huntingtina
|
|
AU2016250843A1
(en)
|
2015-04-24 |
2017-10-12 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
JP2018535969A
(ja)
|
2015-11-04 |
2018-12-06 |
オメロス コーポレーション |
Ｐｄｅ１０阻害剤の固体状態形態
|
|
SG11202004019SA
(en)
|
2017-11-17 |
2020-05-28 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of eye disorders
|